Cancer survival among Alaska Native people

Cancer

Volumn 124, Issue 12, 2018, Pages 2570-2577

  Nash, Sarah H ^a   Meisner, Angela L W ^b   Zimpelman, Garrett L ^a   Barry, Marc ^b,c   Wiggins, Charles L ^b,c  

^a ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

cancer; cause specific survival; Native American

Indexed keywords

ADULT; AGE; AGED; ALASKA NATIVE; ARTICLE; BREAST CANCER; BRONCHUS CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CANCER SURVIVOR; CAUSE SPECIFIC SURVIVAL; COLORECTAL CANCER; DISEASE BURDEN; FEMALE; HUMAN; KIDNEY CANCER; KIDNEY PELVIS CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MIDDLE AGED; PROSTATE CANCER; SEX DIFFERENCE; SURVIVAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; ALASKA; CAUSE OF DEATH; COST OF ILLNESS; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; ETHNOLOGY; KAPLAN MEIER METHOD; MASS SCREENING; MORTALITY; NEOPLASM; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK FACTOR; SEX FACTOR; SEX RATIO;

ADULT; AGE FACTORS; AGED; ALASKA; ALASKA NATIVES; CAUSE OF DEATH; COST OF ILLNESS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; SURVIVAL RATE;

EID: 85044408574     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.31350     Document Type: Article

References (39)

1. White MC, Espey DK, Swan J, Wiggins CL, Eheman C, Kaur JS. Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States. Am J Public Health. 2014;104(suppl 3):S377-S387.
2. Espey DK, Wu XC, Swan J, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer. 2007;110:2119-2152.
3. Wiggins CL, Espey DK, Wingo PA, et al. Cancer among American Indians and Alaska Natives in the United States, 1999-2004. Cancer. 2008;113:1142-1152.
4. Perdue DG, Perkins C, Jackson-Thompson J, et al. Regional differences in colorectal cancer incidence, stage, and subsite among American Indians and Alaska Natives, 1999-2004. Cancer. 2008;113:1179-1190.
5. Kelly JJ, Lanier AP, Alberts S, Wiggins CL. Differences in cancer incidence among Indians in Alaska and New Mexico and US whites, 1993-2002. Cancer Epidemiol Biomarkers Prev. 2006;15:1515-1519.
6. Redwood D, Lanier AP, Renner C, Smith J, Tom-Orme L, Slattery ML. Differences in cigarette and smokeless tobacco use among American Indian and Alaska Native people living in Alaska and the Southwest United States. Nicotine Tob Res. 2010;12:791-796.
7. Espey DK, Jim MA, Richards TB, Begay C, Haverkamp D, Roberts D. Methods for improving the quality and completeness of mortality data for American Indians and Alaska Natives. Am J Public Health. 2014;104(suppl 3):S286-S294.
8. Jim MA, Arias E, Seneca DS, et al. Racial misclassification of American Indians and Alaska Natives by Indian Health Service contract health service delivery area. Am J Public Health. 2014;104(suppl 3):S295-S302.
9. Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med. 2002;162:1985-1993.
10. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004;101:3-27.
11. Cho H, Mariotto AB, Schwartz LM, Luo J, Woloshin S. When do changes in cancer survival mean progress? The insight from population incidence and mortality. J Natl Cancer Inst Monogr. 2014;2014:187-197.
12. Carmack A, Schade TL, Sallison, I, Provost EM, Kelly JJ. Cancer in Alaska Native People: 1969-2013, the 45 Year Report. Anchorage, AK: Alaska Native Epidemiology Center; 2015.
13. Lanier AP, Holck P, Kelly J, Smith B, McEvoy T. Alaska Native cancer survival. Alaska Med. 2001;43:61-69.
14. Alaska Department of Labor and Workforce Development Research and Analysis Section. Alaska population by age, sex, race (alone or in combination) and Hispanic origin, July 2015. http://live.laborstats.alaska.gov/pop/index.cfm. Accessed March 23, 2017.
15. US Census Bureau. 2010 Census summary file 1. https://factfinder.census.gov/faces/nav/jsf/pages/index.xhtml. Accessed March 23, 2017.
16. Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst. 2010;102:1584-1598.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
18. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc. 1972;34:187-220.
19. Mariotto AB, Noone AM, Howlader N, et al. Cancer survival: an overview of measures, uses, and interpretation. J Natl Cancer Inst Monogr. 2014;2014:145-186.
20. Zeng C, Wen W, Morgans AK, Pao W, Shu XO, Zheng W. Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010. JAMA Oncol. 2015;1:88-96.
21. Kalager M, Haldorsen T, Bretthauer M, Hoff G, Thoresen SO, Adami HO. Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study. Breast Cancer Res. 2009;11:R44.
22. Zauber AG. The impact of screening on colorectal cancer mortality and incidence—has it really made a difference? Dig Dis Sci. 2015;60:681-691.
23. Neal RD, Tharmanathan P, France B, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112:S92-S107.
24. Sogaard M, Thomsen RW, Bossen KS, Sorensen HT, Norgaard M. The impact of comorbidity on cancer survival: a review. Clin Epidemiol. 2013;5:3-29.
25. Xu F, Rimm AA, Fu P, Krishnamurthi SS, Cooper GS. The impact of delayed chemotherapy on its completion and survival outcomes in stage II colon cancer patients. PLoS One. 2014;9:e107993.
26. Ortiz-Ortiz KJ, Ramirez-Garcia R, Cruz-Correa M, Rios-Gonzalez MY, Ortiz AP. Effects of type of health insurance coverage on colorectal cancer survival in Puerto Rico: a population-based study. PLoS One. 2014;9:e96746.
27. Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271-289.
28. Alaska Department of Health and Social Services. Colorectal cancer screening health indicator report. http://ibis.dhss.alaska.gov/indicator/view/ColCAScr.AK_US.html. Accessed December 13, 2017.
29. Alaska Department of Health and Social Services. Breast cancer screening health indicator report. http://ibis.dhss.alaska.gov/indicator/view/BreCAScrMam.AK__US.html. Accessed December 13, 2017.
30. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5-29.
31. Jemal A, Ward EM, Johnson CJ, et al. Annual report to the nation on the status of cancer, 1975-2014, featuring survival. J Natl Cancer Inst. 2017;109:djx030.
32. Kelly JJ, Alberts SR, Sacco F, Lanier AP. Colorectal cancer in Alaska Native people, 2005-2009. Gastrointest Cancer Res. 2012;5:149-154.
33. Pietro GD, Chornokur G, Kumar NB, Davis C, Park JY. Racial differences in the diagnosis and treatment of prostate cancer. Int Neurourol J. 2016;20:S112-S119.
34. Powell IJ, Bock CH, Ruterbusch JJ, Sakr W. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. J Urol. 2010;183:1792-1796.
35. Glover M, Kira A, Johnston V, et al. A systematic review of barriers and facilitators to participation in randomized controlled trials by Indigenous people from New Zealand, Australia, Canada and the United States. Glob Health Promot. 2015;22:21-31.
36. Britton A, McKee M, Black N, McPherson K, Sanderson C, Bain C. Threats to applicability of randomised trials: exclusions and selective participation. J Health Serv Res Policy. 1999;4:112-121.
37. Greenland S, Mansournia MA, Altman DG. Sparse data bias: a problem hiding in plain sight. BMJ. 2016;352:i1981.
38. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102:605-613.
39. Withrow DR, Pole JD, Nishri ED, Tjepkema M, Marrett LD. Choice of relative or cause-specific approach to cancer survival analysis impacts estimates differentially by cancer type, population, and application: evidence from a Canadian population-based cohort study. Popul Health Metr. 2017;15:24.